Back
Arbutus Biopharma Vs. Snowflake Industry Stock Comparison
Sell
36
ABUS
Arbutus Biopharma
Last Price:
3.49
Seasonality Move:
15.21%
Buy
100
SNOW
Snowflake
Last Price:
171.51
Seasonality Move:
7.2%
Sell
36
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.46. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Snowflake (SNOW)
is a Buy
Is Snowflake a Buy, Sell or Hold?
- The current Snowflake [SNOW] share price is $171.35. The Score for SNOW is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- SNOW is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
ABUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 30.71 | Sell |
| Chaikin Money Flow: | -475329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.61 - 4.03) | Sell |
| Bollinger Bands (100): | (3.57 - 4.13) | Sell |
SNOW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.7 | Buy |
| Relative Strength Index (14 RSI): | 84.52 | Buy |
| Chaikin Money Flow: | 28023431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.67 - 134.19) | Buy |
| Bollinger Bands (100): | (111.73 - 132.37) | Buy |
ABUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.56 | Sell |
| 20-day SMA: | 3.76 | Sell |
| 50-day SMA: | 3.9 | Sell |
| 200-day SMA: | 3.37 | Buy |
| 8-day EMA: | 3.56 | Sell |
| 20-day EMA: | 3.71 | Sell |
| 50-day EMA: | 3.82 | Sell |
| 200-day EMA: | 3.43 | Buy |
SNOW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.7 | Buy |
| 20-day SMA: | 124.51 | Buy |
| 50-day SMA: | 118.88 | Buy |
| 200-day SMA: | 142.62 | Buy |
| 8-day EMA: | 136.97 | Buy |
| 20-day EMA: | 128.03 | Buy |
| 50-day EMA: | 122.83 | Buy |
| 200-day EMA: | 136.66 | Buy |
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Snowflake Earnings Growth & SNOW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.01 per share, an increase this year of $0.58 per share, and a decrease next year of $0.10 per share.
Arbutus Biopharma Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Snowflake Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||